相关实验视频

Updated: Jul 5, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

耐火性形性星细胞瘤对PCV有反应,可与贝瓦西祖马布联合使用

Arun Swaminathan¹, Donita D Lightner¹, Thomas Pittman²

¹Department of Neurology, University of Kentucky Chandler Medical Center, Lexington, Kentucky, United States.

Case reports in clinical pathology

|January 15, 2024

概括

一名患有复发性形星瘤的患者对普罗卡巴,洛穆斯 (PCV) 和贝瓦齐祖马布的组合表现出了积极的反应. 这种新的第三线疗法在一个高度抗治疗的病例中被证明是有效的.

科学领域:

神经瘤学神经瘤学
临床神经学临床神经学
癌症治疗方法癌症治疗方法

背景情况:

无塑性星瘤是一种侵袭性的原发性脑瘤.
复发的形性星细胞瘤往往呈现治疗耐药性.
标准治疗方案包括手术,放射和化疗 (例如PCV,temozolomide).

研究的目的:

报告复发性形星细胞瘤病例与治疗耐药性.
为了评估第三线治疗的有效性,同时使用普拉卡巴辛,洛穆斯丁 (PCV) 和贝瓦西祖马布.
为了突出对耐火性脑瘤的潜在治疗选择.

主要方法:

病例介绍一个患有形性星细胞瘤的患者.
审查患者的治疗史,包括手术,放射和多种化疗线 (PCV,temozolomide,irinotecan) 和TTF治疗.
与PCV和bevacizumab同时进行第三线治疗的管理.

主要成果:

在最初的手术,放射治疗和一年的PCV治疗后,患者经历了疾病复发.
随后用temozolomide,irinotecan与bevacizumab,以及Novocure TTF治疗的治疗,在四年内显示出反应不佳.
该患者对第三线治疗与同时使用PCV和bevacizumab的治疗产生了积极反应.

结论:

同时使用PCV和贝瓦齐祖马布,在患有耐火性形性星细胞瘤的患者中,证明了作为第三线治疗的有效性.
这种组合疗法代表了高度治疗耐药的大脑瘤的新方法.
需要对这种治疗策略进行进一步的研究,以治疗复发性质瘤.

关键词:

无塑性星系细胞瘤 (Anaplastic astrocytoma) 是一种无塑性星系细胞瘤.大脑瘤是什么?复发性瘤的复发情况治疗瘤的治疗方法

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...